Glow

Overview

Systemic cellular regulation and multi vector functional support.

Mechanism of action

From a scientific standpoint, combining peptides does not automatically create additive or synergistic effects in humans—because pharmacokinetics, stability, dosing equivalence, and safety interactions are usually not validated in clinical trials for blends. A careful description should therefore frame GLOW as a research blend concept rather than a proven therapy.

• BPC 157 (a gastric derived pentadecapeptide studied in preclinical injury and inflammation models),
• TB 500 (a short thymosin beta 4 fragment associated with actin dynamics and cell movement in tissue repair biology), and
• GHK Cu (a copper binding tripeptide widely studied in skin biology, remodeling, and gene expression effects).

Mechanistically, this “stack” combines:

GLOW is not a single molecule—it’s a formulation name commonly used for a blend of BPC 157 + TB 500 + GHK Cu. In research and wellness marketing contexts, the blend is positioned around “regeneration” themes because each component has been studied (to varying degrees) in tissue repair signaling, cell migration, and extracellular matrix regulation.

Authenticity

To validate your product, scan the QR code on the packaging or open the verification page for this product group.